Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Epoetin Alfa in Peritoneal Dialysis Patients
NCT00442416Phase 3Terminated
- Sponsor
- Roche
- Start
- Feb 2007
- Primary completion
- Jan 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia, sponsored by Roche. Started Feb 2007; status: terminated.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00442416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442416.